Indication Phenotypes and Short‑Term Clinical Outcomes in Patients Undergoing Left Atrial Appendage Closure: A Single‑Center Real‑World Experience from Türkiye.
TL;DR
Among patients undergoing LAAO, no statistically significant differences in short‑ term clinical outcomes were observed according to indication phenotype and age emerged as the most consistent determinant of risk.
Abstract
Objective
Left atrial appendage occlusion (LAAO) is widely used for stroke prevention in patients with atrial fibrillation who are unsuitable for long‑term anticoagulation. However, whether clinical outcomes differ according to indication phenotype (bleeding‑dominant versus ischemic‑dominant) remains unclear. This study aimed to evaluate the association between indication phenotype and clinical outcomes following LAAO and to determine whether phenotype provides incremental prognostic value beyond traditional risk factors.
Method
In this retrospective single‑center study, patients undergoing LAAO were classified as having either a bleeding‑dominant or ischemic‑dominant indication phenotype. The primary outcome was all‑cause mortality. The secondary outcome was a net clinical benefit composite consisting of death, recurrent stroke, or major bleeding. Associations were assessed using Kaplan-Meier and Cox analyses, and the proportional hazards assumption was tested using Schoenfeld residuals. Sensitivity analyses were performed after excluding major bleeding from the composite outcome.
Results
A total of 109 consecutive patients were included. During a median follow‑up of approximately 10 months, all‑cause mortality occurred in 25.7% of patients, while the net clinical benefit composite occurred in 29.4%. No statistically significant association was observed between indication phenotype and mortality (adjusted hazard ratio [HR] 1.00, 95% confidence interval [CI] 0.38-2.62) or the composite outcome (adjusted HR 0.73, 95% CI 0.30-1.78). However, the wide confidence intervals reflect the limited sample size and event burden.
Conclusion
Among patients undergoing LAAO, no statistically significant differences in short‑ term clinical outcomes were observed according to indication phenotype. Age emerged as the most consistent determinant of risk. Given the modest sample size, limited number of events, and relatively short follow‑up duration, these findings should be interpreted cautiously and considered hypothesis‑generating.